News
Resources
Blog
Sites
Novel medicines approved in 2022 offer increased treatment options for patients
By Andrew Powaleny | January 23, 2023
2022 marked another year of significant progress by biopharmaceutical research companies conducting lifesaving research and development for innovative medicines with a total of 45 new medicine...
Read More
ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference
By Katie Koziara | January 19, 2023
This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed...
Read More
WTAS: Inflation Reduction Act already impacting R&D decisions
By Nicole Longo | January 17, 2023
The Inflation Reduction Act’s (IRA’s) drug price setting provisions, as predicted, are already impacting biopharmaceutical research & development (R&D) decisions. Whether you are looking at estimates...
Read More
Stories from the lab: Researchers discuss innovative treatments for cancers of the blood
By Matthew Norawong | December 1, 2022
The biopharmaceutical industry is one of the most research-intensive of all sectors in the U.S. economy and supports a broad range of STEM jobs through R&D and manufacturing. At the backbone of the...
Read More
Expanding TRIPS waiver would jeopardize biopharmaceutical research and development
By Megan Van Etten | November 17, 2022
The United States has led the charge in the development of vaccines and treatments to combat COVID-19 thanks in large part to our robust innovation ecosystem, supported by intellectual property (IP)...
Read More
New government price setting policy threatens post-approval research
By Nicole Longo | November 10, 2022
Have you ever noticed that one medicine might be used to treat two, three, seven different conditions? That’s the result of significant additional research and investment, including lengthy and...
Read More
Congratulations to our 2022 Working for Cures Employee Champions
By Stephen J. Ubl | November 10, 2022
The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.
Read More
ICYMI: PhRMA COO Lori Reilly Esq. speaks with Jacob Van Naarden about the future of cancer research
By Emilie Signora | November 8, 2022
Our health care ecosystem has made tremendous progress in the fight against cancer, with the cancer death rate falling 32% from its peak in 1991. On November 3, PhRMA sponsored The Atlantic’s People...
Read More
New paper: Addressing the growing crisis of mental health and substance use disorders
By Lindsey Seidlitz | November 7, 2022
The United States is facing a crisis of mental health and addiction that has left few Americans and families unimpacted by these illnesses and the devastating consequences that are often associated...
Read More
Protecting treatment advances for breast cancer
By Jocelyn Ulrich | October 31, 2022
Since the 1980s, October has been recognized as National Breast Cancer Awareness Month — an opportunity for us to unite as a community to honor those who have had breast cancer and raise awareness...
Read More
Medicare Monday (100)
340B Spotlight (46)
Cost & Consequence (0)
